For years now, AI has been helping scientists in physics, material science, and healthcare make bold advances that benefit society. “I call this the golden era of biomedicine,” says physician-scientist Anna Greka, MD, PhD, Professor of the Broad Institute of MIT and Harvard. “I really think that we have unprecedented tools. The onus is on us to actually use them for the benefit of humanity.” Alongside her team of “molecular sleuths,” Anna is using AI to revolutionize disease research. In our third episode of Dialogues Dispatch, Anna joins Google’s James Manyika for a conversation about AI as a game-changer to help humanity scale research and drive breakthroughs in health and science. In addition to discussing how AI has transformed her work, Anna emphasizes the importance of collaboration in making sure these efforts are inclusive and using the tools at our disposal to benefit everyone. Listen to the full episode on YouTube, Apple, or Spotify. https://goo.gle/3WlhURt
Google Public Policy’s Post
More Relevant Posts
-
It was awesome to have the super insightful Alex Zhavoronkov on the show to learn all about aging and AI drug discovery. Check out the full ep here: https://lnkd.in/eD6dvbEs
What exactly is aging... and can AI really help us cure, stop, or even reverse it? This week I spoke with Alex Zhavoronkov, founder and CEO at Insilico Medicine and expert in artificial intelligence for drug discovery and aging research, to understand how his work with AI is transforming drug discovery and helping solve the aging riddle. Since 2014 Alex has published and co-published over 170 peer-reviewed publications and raised over $400 million in capital. He also has an incredible six clinical trials for drugs discovered using AI. In the show, we cover: - What aging is, exactly - How generative chemistry is helping discover new drugs - Processes around pre-clinical and clinical trials - Multi-modal transformers in aging research ... and much more. Check out the full episode here: Spotify: https://lnkd.in/exVKa3E9 Apple: https://lnkd.in/ehMW9xxd YouTube: https://lnkd.in/eeqRef2T
To view or add a comment, sign in
-
What exactly is aging... and can AI really help us cure, stop, or even reverse it? This week I spoke with Alex Zhavoronkov, founder and CEO at Insilico Medicine and expert in artificial intelligence for drug discovery and aging research, to understand how his work with AI is transforming drug discovery and helping solve the aging riddle. Since 2014 Alex has published and co-published over 170 peer-reviewed publications and raised over $400 million in capital. He also has an incredible six clinical trials for drugs discovered using AI. In the show, we cover: - What aging is, exactly - How generative chemistry is helping discover new drugs - Processes around pre-clinical and clinical trials - Multi-modal transformers in aging research ... and much more. Check out the full episode here: Spotify: https://lnkd.in/exVKa3E9 Apple: https://lnkd.in/ehMW9xxd YouTube: https://lnkd.in/eeqRef2T
To view or add a comment, sign in
-
How can we use aging research as a platform for drug discovery? Here, I jumped on a call with Tom Edwards to discuss
What exactly is aging... and can AI really help us cure, stop, or even reverse it? This week I spoke with Alex Zhavoronkov, founder and CEO at Insilico Medicine and expert in artificial intelligence for drug discovery and aging research, to understand how his work with AI is transforming drug discovery and helping solve the aging riddle. Since 2014 Alex has published and co-published over 170 peer-reviewed publications and raised over $400 million in capital. He also has an incredible six clinical trials for drugs discovered using AI. In the show, we cover: - What aging is, exactly - How generative chemistry is helping discover new drugs - Processes around pre-clinical and clinical trials - Multi-modal transformers in aging research ... and much more. Check out the full episode here: Spotify: https://lnkd.in/exVKa3E9 Apple: https://lnkd.in/ehMW9xxd YouTube: https://lnkd.in/eeqRef2T
To view or add a comment, sign in
-
Who else is attending 𝗦𝗫𝗦𝗪 𝟮𝟬𝟮𝟰? Because we will be there! Our CEO Andreas Forsland will be speaking on the panel "𝗧𝗵𝗶𝘀 𝗶𝘀 𝗬𝗼𝘂𝗿 𝗕𝗿𝗮𝗶𝗻 𝗼𝗻 𝗔𝗜: 𝗡𝗲𝘂𝗿𝗼𝘁𝗲𝗰𝗵'𝘀 𝗡𝗲𝘄 𝗛𝗼𝗿𝗶𝘇𝗼𝗻𝘀" Let us know if you'll be in Austin for SXSW, should we do a meetup of the minds 🧠 ? #PresenterSXSW #SXSWPresenter #SXSW https://lnkd.in/gjcid3RZ Panel information: What will the next generation of AI-powered neurotechnology devices enable? How will these new AI advancements redefine the User Experience of Brain Computer Interfaces (BCI’s). Dive into the intersection of neuroscience, artificial intelligence, and design to explore the unfolding realm of BCI’s. Featuring a lineup of pioneering thought leaders, founders, and creative technologists, this panel will cover AI’s existing relationship with BCI’s and highlight how a new generation of AI will unlock powerful use cases for BCI’s in the future.
To view or add a comment, sign in
-
CZB's CELLxGENE is a testament of big data driving biology, an impressive collection of single cell sets (including scRNAseq, Visium, slide-seq, and some other spatial data too). Science is moving fast that utilizing the right technologies can transform a 6 months 3 people project into roughly 1 month (based on 1st hand experiences - primary cell differentiation to sequencing). Don't just focus on science, focus on technology enabled science too. Mining these atlases will help us "search & rescue" cells of interests, and it's free. #scRNAseq #AI #CELLxGENE https://lnkd.in/g7CEQXky
To help scientists cure, prevent or manage all diseases, we need new breakthroughs in understanding the human body and how our cells work. Mark and I think AI holds incredible promise to help researchers accelerate progress in this area. That’s why we’re building one of the largest computing clusters in the world for non-profit life science research with the goal of using it to create a new type of virtual cell that would give scientists worldwide access to a digital model that could predict the behavior of any cell type. Researchers could use it to answer questions like how an immune cell will react to an infection or what’s happening at the cellular level when a child is born with a rare disease. CZI has been building towards this moment by working with the scientific community to generate large, integrated single-cell datasets required to train AI models and building open source tools to help researchers make the most of these datasets. We hope that this new, collaborative effort will generate insights about the fundamental characteristics of our cells and help researchers harness the power of AI to make progress against diseases. #science #artificialintelligence
To view or add a comment, sign in
-
Scientists are using AI for new cancer therapies, locating endangered whales, in the ocean, and engineering hardware for space exploration. How does science research with AI differ from society and what does it mean for STEM educators? My podcast (STEM)2 explores this and more within the context of a developmental model for AI in K-12 education.
(STEM)2 S5E1 - Series 5 Episode 1: Exploring “The Cosmos” with K-12 Students Augmented by AI - A Developmental Model for Science Educators - The Power of (STEM)2
https://www.spreaker.com/
To view or add a comment, sign in
-
So much in awe of the Google Research team in collaboration with Harvard University for studying connectomics to figure out how our brains which consume such little energy are capable of feats that our largest AI systems can't do yet. This connectome describes a piece of human brain tissue the size of half a grain of rice that nonetheless requires 1.4 petabytes (1.4 million gigabytes) to encode — including about 16,000 neurons, 32,000 glia, 8,000 blood vessel cells (for a total of ~57,000 cells) and 150 million synapses. This research may change our understanding of how our brains work. #GoogleResearch #GoogleConnectomics #GoogleDeepMind
Ten years of neuroscience at Google yields maps of human brain
research.google
To view or add a comment, sign in
-
Reference for my neiro class
🔥Breaking: AI reconstructed a Pink Floyd song from the brain activities.🧠 Neuroscientists decode songs from brain recordings, revealing areas dealing with rhythm and vocals. Neuroscientists recorded brain activity while patients listened to Pink Floyd's "Another Brick in the Wall, Part 1". To Decode the electrical activity of brain regions related to musical elements of the song. Results: Successfully reconstructed the song using AI✔ The technology could assist people who have trouble communicating due to stroke or paralysis. It may enhance the musicality of speech in robotic voice reconstructions or might help in adding emotional content to future brain implants. Future advancements could allow for recordings without opening the brain.🚀 Through this experiment, new areas of the brain associated with rhythm detection were discovered. Also, the right side of the brain was found to be more attuned to music than the left side. Credit University of Berkeley #artificialintelligence
To view or add a comment, sign in
10,872 followers